Suryadevara Manika, Bonville Cynthia A, Cibula Donald A, Domachowske Joseph B
Department of Pediatrics, SUNY Upstate Medical University, Syracuse, NY, USA.
Department of Public Health and Preventive Medicine, SUNY Upstate Medical University, Syracuse, NY, USA.
Hum Vaccin Immunother. 2021 Apr 3;17(4):1052-1058. doi: 10.1080/21645515.2020.1812316. Epub 2020 Oct 16.
We introduced a multi-component cancer prevention awareness program to primary care practices across New York State to evaluate its impact on adolescent human papillomavirus (HPV) vaccination rates.
Eight pediatric and three family medicine practices were recruited to participate in this program. On-site training sessions were provided for all practice providers and staff to discuss the importance of HPV vaccine and cancer prevention and teach strategies for delivering a strong vaccine recommendation. Each practice received a study-specific booklet that included HPV vaccine information and other commonly provided cancer prevention guidance. These booklets were distributed to all adolescents and their parents during well visits over a one-year period. Practice specific and county-wide HPV vaccination rates were assessed before and 12 months after the program training session.
One year after program initiation, aggregate data show statistically higher vaccine series initiation rates among 11-12 and 13-18-year-olds and higher vaccine series completion rates among 13-18-year-olds. The greatest and most consistent improvements were seen in vaccine initiation rates for the 11-12-year-old cohort. Disparities in vaccine uptake were observed by gender and medical specialty.
Cancer prevention education targeting providers, office staff, patients, and parents, improved adolescent HPV vaccine series initiation rates.
我们在纽约州的基层医疗实践中引入了一项多组分癌症预防意识项目,以评估其对青少年人乳头瘤病毒(HPV)疫苗接种率的影响。
招募了8家儿科诊所和3家家庭医学诊所参与该项目。为所有诊所的医护人员和工作人员提供了现场培训课程,以讨论HPV疫苗和癌症预防的重要性,并教授提供有力疫苗推荐的策略。每家诊所都收到了一本针对该研究的手册,其中包含HPV疫苗信息和其他常见的癌症预防指导。这些手册在为期一年的健康检查期间分发给所有青少年及其父母。在项目培训课程之前和之后12个月评估诊所特定的和全县范围的HPV疫苗接种率。
项目启动一年后,汇总数据显示,11至12岁和13至18岁人群中疫苗系列起始率在统计学上更高,13至18岁人群中疫苗系列完成率更高。在11至12岁队列的疫苗起始率方面观察到了最大且最一致的改善。在疫苗接种方面存在性别和医学专业差异。
针对医护人员、办公室工作人员、患者和家长的癌症预防教育提高了青少年HPV疫苗系列起始率。